Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Bioorg Med Chem ; 18(13): 4674-86, 2010 Jul 01.
Article in English | MEDLINE | ID: mdl-20570526

ABSTRACT

A series of new ureidoindolin-2-one derivatives were synthesized and evaluated as inhibitors of receptor tyrosine kinases. Investigation of structure-activity relationships at positions 5, 6, and 7 of the oxindole skeleton led to the identification of 6-ureido-substituted 3-pyrrolemethylidene-2-oxindole derivatives that potently inhibited both the vascular endothelial growth factor receptor (VEGFR) and platelet-derived growth factor receptor (PDGFR) families of receptor tyrosine kinases. Several derivatives showed potency against the PDGFR inhibiting both its enzymatic and cellular functions in the single-digit nanomolar range. Among them, compound 35 was a potent inhibitor against tyrosine kinases, including VEGFR and PDGFR families, as well as Aurora kinases. Inhibitor 36 (non-substituted on the pyrrole or phenyl ring) had a moderate pharmacokinetic profile and completely inhibited tumor growth initiated with the myeloid leukemia cell line, MV4-11, in a subcutaneous xenograft model in BALB/c nude mice.


Subject(s)
ErbB Receptors/antagonists & inhibitors , Indoles/chemistry , Protein Kinase Inhibitors/chemical synthesis , Protein Serine-Threonine Kinases/antagonists & inhibitors , Pyrroles/chemistry , Receptors, Platelet-Derived Growth Factor/antagonists & inhibitors , Urea/analogs & derivatives , Animals , Aurora Kinases , Binding Sites , Cell Line, Tumor , Computer Simulation , Drug Screening Assays, Antitumor , ErbB Receptors/metabolism , Humans , Indoles/therapeutic use , Indoles/toxicity , Leukemia, Myeloid/drug therapy , Mice , Oxindoles , Protein Kinase Inhibitors/therapeutic use , Protein Kinase Inhibitors/toxicity , Protein Serine-Threonine Kinases/metabolism , Pyrroles/therapeutic use , Pyrroles/toxicity , Receptors, Platelet-Derived Growth Factor/metabolism , Structure-Activity Relationship , Transplantation, Heterologous , Urea/chemistry , Urea/therapeutic use , Urea/toxicity
2.
Eur J Med Chem ; 40(11): 1143-8, 2005 Nov.
Article in English | MEDLINE | ID: mdl-16040160

ABSTRACT

Spiro derivatives of oxindole and isoxazole-5-one were synthesized by using Michael addition reaction, highlighting the regioselective approach towards the synthesis of Michael diadduct followed by condensation of Michael diadduct. The spiro compound 4 showed antitubercular activity against Mycobacterium tuberculosis H37Rv whereas spiro compound 9 possesses pronounced anticancer and antibacterial profile.


Subject(s)
Androstenols/chemical synthesis , Anti-Bacterial Agents/chemical synthesis , Antineoplastic Agents/chemical synthesis , Antitubercular Agents/chemical synthesis , Spiro Compounds/chemical synthesis , Alkylation , Animals , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/toxicity , Antineoplastic Agents/pharmacology , Antitubercular Agents/pharmacology , Cell Survival/drug effects , Drug Design , Drug Screening Assays, Antitumor , Indoles/chemical synthesis , Mice , Microbial Sensitivity Tests , Spiro Compounds/pharmacology , Spiro Compounds/toxicity , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...